Polynovo Limited · ASX:PNV
Polynovo — H1 2024 Earnings Presentation
13 slides from Polynovo's earnings presentation, Feb 27, 2024
Slide 1: 1H FY24 Results: Accelerating Global Impact
2 PolyNovo: 1H FY24 Results (in conjunction with Appendix 4D) Accelerating Global Impact 27 February 2024 Healing. Redefined.
Slide 2: Disclaimer
Disclaimer ‘@ PolyNovo: Healing. Redefined. This presentation has been prepared by PolyNovo Limited and is provided for general information purposes only. No party other than PolyNovo has authorised or caused the issue of this document, or takes responsibility for, or makes any statements, represent
Slide 3: Accelerating Global Impact
Accelerating Global Impact & PolyNovo: Healing. Redefined. PolyNovo has treated over 37K patients in 37 countries in its short history. Hospital accounts are now 861 up from 515 STLY. Strong global revenue of A$48.8m for 1H24 up 65.6% on STLY * US. revenue of A$32.2mup 41.7% on STLY * ROW revenue of
Slide 4: 1H FY24 Financial Results Review
#@) PolyNovo' 1H FY24 Financial Results Review
Slide 5: Revenue Growth
Revenue Growth & PolyNovo: Healing. Redefined. Total revenue growth $60.0m $50.0m 62.2% $40.0m t $30.0m 25.3% t t $18.2m $20.0m $10.2m $12.8m “a a $0.0m 1H20 1H21 1H22 1H23 Other $0.0m $0.1m $0.1m $0.1m ™BARDA $1.6m $1.4m $1.8m $2.1m mNovoSorb $8.6m $11.3m $16.3m $27.3m 65.6% $48.8m 1H24 $1.7m $4.9m
Slide 6: Sales Growth
Sales Growth & PolyNovo: Healing. Redefined. Product sales by region $45.0m $40.0m 67.5% $35.0m t $30.0m $27.3m $25.0m “ 31.2% $20.0m t $16.3m $15.0m $11.3m $10.0m $8.6m $0.0m 1H20 1H21 1H22 1H23 = ROW $1.8m $2.3m $2.1m $4.5m mUSA $6.8m $9.0m $14.2m $22.8m 1H24 $10.0m $32.2m Highlights: * Record 1H
Slide 7: Capital Efficient Growth
Capital Efficient Growth & PolyNovo: Healing. Redefined. Revenue, opex, underlying NPAT* $48.8m $42.9m $30.2m $29.5m $1 8.2m>19-0m $12.8m $10.2m910-3m $12.4m $5.7m ($1.0m) ($0.3m) ($1.7m) ($2.2m) Revenue Opex NLAT |Revenue Opex NLAT |Revenue Opex NLAT |Revenue Opex NLAT [Revenue Opex NPAT 1H20 1H21
Slide 8: Capital Efficient Growth
Capital Efficient Growth & PolyNovo: Healing. Redefined. Cash flow breakdown $50.5m $0.7m $3.3m___ $46.8m $0.6m _$0.6m $45.6m ($4.0m) ($1.5m) ($2.2m) ($1.1m) (§1.3m) ie) oS a $ re) so $ Veo § vw w& @ ye Mew § @ @ @ © MO FE E§ 88 EE EE SE EF ES FE EEEE YS €F FE BF LE EE SP EF FE BE EF FR SP SE WS CF
Slide 9: 1H FY24 Financial Results
1H FY24 Financial Results & PolyNovo: Healing. Redefined. Income Statement ($m) 1H24 1H23 Change % Total revenue (excluding interest income) 479 29.4 63.0% Operating expenses (44.3) (31.4) 41.3% Operating profit/(loss) 3.6 (2.0) -285.7% Share based payments (0.6) (0.6) 12.9% Unrealised forex gain/(
Slide 10: Accelerating Global Impact
Accelerating Global Impact & PolyNovo: Healing. Redefined. Uniquely situated to drive global growth * Genius technology * Underserved market * Capital efficient growth and scaling Excited about our Platform technology 3 * Graftable and Implantable } * Science of Acute Complex Wounds * Our growth wil
Slide 11: Slide 11
Slide 12: Appendix
Appendix ‘@ PolyNovo: Healing. Redefined. Income Statement Balance Sheet ($m) 1H24 1H23 Change % ($m) 1H24 1H23 Change % Total revenue (exclu: interest income) 479 29.4 63.0% Cash and cash equivalent 45.6 40.8 -2.7% Operating expenses (44.3) (31.4) 41.3% Trade and other receivables 15.3 13.7 12.0% O
Slide 13: Hospitals and Employees
Hospitals and Employees & PolyNovo: Healing. Redefined. Customers Employees (Hospitals) 861 337 173 515 122 361 1 95 29 5 1H20 1H21 1H22 1H23 1H24 1H20 1H21 1H22 1H23 1H24